Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Liberty Latin America Ltd.LILA · Entity 4630 | MD, CHIEF ACCOUNTING OFFICER | June 16, 2026 | July 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Liberty Latin America Ltd.
Report date June 16, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Preference SharesSEC Table I · non-derivative | Direct | 4,918 |
Reported balance
After 2026-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-16 · Other · Acquired 4,918 · Balance 4,918 F1: On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares. |
| Series A Preference SharesSEC Table I · non-derivative | IndirectBy IRA | 140 |
Reported balance
After 2026-06-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-16 · Other · Acquired 140 · Balance 140 F2: As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account. |
| Restricted Share Units PSEC Table II · derivative / convertible security | Direct | 2,164 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Other · Acquired 2,164 · Balance 2,164 F3: Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement. F4: The RSUs vest in full on March 15, 2027. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $13.03 · Expires 2028-05-01 | Direct | 15,170 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 15,170 F5: The derivative security is fully vested. F6: This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $13.93 · Expires 2029-05-01 | Direct | 14,847 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 14,847 F5: The derivative security is fully vested. F8: This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $7.29 · Expires 2030-03-16 | Direct | 26,709 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 26,709 F5: The derivative security is fully vested. F10: This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $9.80 · Expires 2031-03-16 | Direct | 47,666 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 47,666 F5: The derivative security is fully vested. F12: This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $9.80 · Expires 2031-03-16 | Direct | 23,699 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 23,699 F5: The derivative security is fully vested. F14: This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $6.78 · Expires 2032-03-11 | Direct | 36,386 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 36,386 F5: The derivative security is fully vested. F16: This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $5.47 · Expires 2033-03-20 | Direct | 23,626 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 23,626 F5: The derivative security is fully vested. F18: This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $4.31 · Expires 2034-03-12 | Direct | 29,303 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 29,303 F20: The SARs vest in full on March 15 2027. F21: This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $4.68 · Expires 2035-03-14 | Direct | 27,082 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 27,082 F23: The SARs vest in two equal annual installments on March 15 of 2027 and 2028. F24: This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $5.31 · Expires 2036-03-13 | Direct | 23,978 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 23,978 F26: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. F27: This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $12.41 · Expires 2028-05-01 | Direct | 31,190 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 31,190 F5: The derivative security is fully vested. F7: This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $13.63 · Expires 2029-05-01 | Direct | 30,526 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 30,526 F5: The derivative security is fully vested. F9: This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $7.13 · Expires 2030-03-16 | Direct | 54,913 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 54,913 F5: The derivative security is fully vested. F11: This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $9.60 · Expires 2031-03-16 | Direct | 98,000 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 98,000 F5: The derivative security is fully vested. F13: This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $9.60 · Expires 2031-03-16 | Direct | 48,724 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 48,724 F5: The derivative security is fully vested. F15: This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $6.56 · Expires 2032-03-11 | Direct | 74,808 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 74,808 F5: The derivative security is fully vested. F17: This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $5.30 · Expires 2033-03-20 | Direct | 48,574 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 48,574 F5: The derivative security is fully vested. F19: This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $4.24 · Expires 2034-03-12 | Direct | 60,246 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 60,246 F20: The SARs vest in full on March 15 2027. F22: This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $4.54 · Expires 2035-03-14 | Direct | 55,682 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 55,682 F23: The SARs vest in two equal annual installments on March 15 of 2027 and 2028. F25: This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $5.29 · Expires 2036-03-13 | Direct | 49,297 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 49,297 F26: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. F28: This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares.
F2: As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account.
F3: Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
F4: The RSUs vest in full on March 15, 2027.
F5: The derivative security is fully vested.
F6: This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F7: This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F8: This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F9: This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F10: This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F11: This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F12: This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F13: This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F14: This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F15: This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F16: This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F17: This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F18: This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F19: This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F20: The SARs vest in full on March 15 2027.
F21: This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F22: This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F23: The SARs vest in two equal annual installments on March 15 of 2027 and 2028.
F24: This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F25: This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F26: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
F27: This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F28: This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jul 18, 2026 00:12 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherRestricted Share Units P · Derivative | 2,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001725076-26-000003 · wk-form4_1784333569.xml · derivative · entry 3 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,164 Underlying: Series A Preference Shares · 2,164 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement. F4 · derivative.exercise_date: The RSUs vest in full on March 15, 2027. F4 · derivative.expiration_date: The RSUs vest in full on March 15, 2027. Read SEC document |
| June 16, 2026 Filed Jul 18, 2026 00:12 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherSeries A Preference Shares | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0001725076-26-000003 · wk-form4_1784333569.xml · nonDerivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 140 F2 · balance_after: As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account. Read SEC document |
| June 16, 2026 Filed Jul 18, 2026 00:12 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherSeries A Preference Shares | 4,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001725076-26-000003 · wk-form4_1784333569.xml · nonDerivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,918 F1 · balance_after: On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units C · Derivative | 14,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · derivative · entry 17 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,436 Underlying: Class C Common Shares · 14,436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. F4 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units A · Derivative | 7,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · derivative · entry 16 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,218 Underlying: Class A Common Shares · 7,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. F4 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units C · Derivative | 11,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · derivative · entry 15 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 11,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units A · Derivative | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · derivative · entry 14 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 5,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass C Common Shares | 4,151 | $7.77 | $32,253.27 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 8 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,168 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass C Common Shares | 14,436 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 7 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass C Common Shares | 3,278 | $7.77 | $25,470.06 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 6 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,883 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass C Common Shares | 11,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 5 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass A Common Shares | 2,076 | $7.58 | $15,736.08 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 4 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,016 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass A Common Shares | 7,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 3 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass A Common Shares | 1,639 | $7.58 | $12,423.62 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,874 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass A Common Shares | 5,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · nonDerivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights C · Derivative | 33,536 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · derivative · entry 13 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,536 Underlying: Class C Common Shares · 33,536 shares Expires 2036-03-13 F2 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:42 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights A · Derivative | 16,768 | $0.00 Strike: $7.58 | $0.00 |
DisclosureSEC source: 0001712184-26-000041 · wk-form4_1773783749.xml · derivative · entry 12 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,768 Underlying: Class A Common Shares · 16,768 shares Expires 2036-03-13 F2 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | SaleClass C Common Shares | 60,595 | $8.07 | $489,056.19 |
DisclosureSEC source: 0001712184-26-000027 · wk-form4_1771968678.xml · nonDerivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,760 F2 · price: The price reflects a weighted average of sales made at prices ranging from $7.9073 to $8.1900. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | SaleClass A Common Shares | 33,899 | $7.97 | $270,283.51 |
DisclosureSEC source: 0001712184-26-000027 · wk-form4_1771968678.xml · nonDerivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,813 F1 · price: The price reflects a weighted average of sales made at prices ranging from $7.8100 to $8.0800. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units C · Derivative | 14,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 23 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,872 Underlying: Class C Common Shares · 14,436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F5 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. F5 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units C · Derivative | 11,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 22 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,401 Underlying: Class C Common Shares · 11,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. F4 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units C · Derivative | 7,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 21 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 7,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2023, 2024 and 2025. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2023, 2024 and 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units A · Derivative | 7,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 20 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,436 Underlying: Class A Common Shares · 7,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F5 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. F5 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2025, 2026 and 2027. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units A · Derivative | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 19 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,700 Underlying: Class A Common Shares · 5,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. F4 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2024, 2025 and 2026. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionRestricted Share Units A · Derivative | 3,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 18 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 3,819 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments on March 15 of 2023, 2024 and 2025. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments on March 15 of 2023, 2024 and 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass C Common Shares | 4,134 | $6.66 | $27,532.44 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 12 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,355 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass C Common Shares | 14,436 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 11 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass C Common Shares | 3,278 | $6.66 | $21,831.48 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 10 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,053 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass C Common Shares | 11,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 9 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass C Common Shares | 2,196 | $6.66 | $14,625.36 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 8 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,930 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass C Common Shares | 7,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 7 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass A Common Shares | 2,076 | $6.69 | $13,888.44 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 6 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,712 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass A Common Shares | 7,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 5 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass A Common Shares | 1,639 | $6.69 | $10,964.91 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 4 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,570 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass A Common Shares | 5,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 3 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass A Common Shares | 1,098 | $6.69 | $7,345.62 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,509 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass A Common Shares | 3,819 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · nonDerivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights C · Derivative | 37,879 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 17 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,879 Underlying: Class C Common Shares · 37,879 shares Expires 2035-03-14 F2 · derivative.exercise_date: The SARs vest in three equal annual installments on March 15 of 2026, 2027 and 2028. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:31 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights A · Derivative | 18,939 | $0.00 Strike: $6.69 | $0.00 |
DisclosureSEC source: 0001712184-25-000067 · wk-form4_1742333504.xml · derivative · entry 16 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,939 Underlying: Class A Common Shares · 18,939 shares Expires 2035-03-14 F2 · derivative.exercise_date: The SARs vest in three equal annual installments on March 15 of 2026, 2027 and 2028. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights C · Derivative | 37,356 | Not disclosed Strike: $10.48 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 12 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,356 Underlying: Class C Common Shares · 37,356 shares Expires 2030-03-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Disposition to issuerShare Appreciation Rights C · Derivative | 37,356 | Not disclosed Strike: $10.48 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 11 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 37,356 shares Expires 2027-03-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights C · Derivative | 20,766 | Not disclosed Strike: $20.03 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 10 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,766 Underlying: Class C Common Shares · 20,766 shares Expires 2029-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Disposition to issuerShare Appreciation Rights C · Derivative | 20,766 | Not disclosed Strike: $20.03 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 9 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 20,766 shares Expires 2026-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights C · Derivative | 21,218 | Not disclosed Strike: $18.24 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 8 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,218 Underlying: Class C Common Shares · 21,218 shares Expires 2028-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Disposition to issuerShare Appreciation Rights C · Derivative | 21,218 | Not disclosed Strike: $18.24 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 7 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Shares · 21,218 shares Expires 2025-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights A · Derivative | 18,678 | Not disclosed Strike: $10.42 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 6 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,678 Underlying: Class A Common Shares · 18,678 shares Expires 2030-03-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Disposition to issuerShare Appreciation Rights A · Derivative | 18,678 | Not disclosed Strike: $10.42 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 5 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 18,678 shares Expires 2027-03-16 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights A · Derivative | 10,383 | Not disclosed Strike: $19.91 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 4 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,383 Underlying: Class A Common Shares · 10,383 shares Expires 2029-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Disposition to issuerShare Appreciation Rights A · Derivative | 10,383 | Not disclosed Strike: $19.91 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 3 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Shares · 10,383 shares Expires 2026-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 20:08 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights A · Derivative | 10,609 | Not disclosed Strike: $18.63 | Not disclosed |
DisclosureSEC source: 0001712184-24-000242 · wk-form4_1729800501.xml · derivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,609 Underlying: Class A Common Shares · 10,609 shares Expires 2028-05-01 F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply. F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.